Ruto: Cancer drug prices slashed sevenfold in Pfizer deal
President Ruto said the reduction would, in some cases, bring the cost of a single treatment cycle from as much as Sh1 million to below Sh50,000...
✨ Key Highlights
President William Ruto announced a landmark deal with pharmaceutical giant Pfizer that will drastically reduce the cost of cancer drugs in Kenya, cutting prices by more than sevenfold.
- The price of cancer medicines for several types of cancer, including breast, stomach, and lung cancer, has been reduced by more than seven times.
- Key players include President William Ruto, the Kenyan government, and Pfizer, facilitated through the Kenya Medical Supplies Authority (KEMSA).
- This agreement, part of Pfizer's Accord for a Healthier World initiative, aims to make cancer treatment more affordable and strengthen Kenya's Universal Health Coverage programme, potentially bringing a Sh1 million treatment cycle down to below Sh50,000.
Continue Reading
Read the complete article from Capital News
Part of the Day's Coverage
Kenya Seals Deal with Pfizer to Cut Cancer Drug Prices Sevenfold - September 2026
President William Ruto announced a landmark deal with pharmaceutical giant Pfizer that will drastically reduce the cost of cancer drugs in Kenya, cutting prices by more than sevenfold. Kenya secured the deal under Pfizer's Accord for a Healthier World programme, expected to cut treatment expenses by over seven times for several types of cancer. Separately, Kenya is intensifying efforts to implement universal infant screening for sickle cell disease, aiming to improve early diagnosis and treatment for the estimated 250,000 people living with the condition. The Africa Centres for Disease Control and Prevention was appointed to represent regional health organizations globally on the Joint Task Force on Global Health Architecture Reform.
